Back

Summary of Edition of 28 October 2024

DeCODe: A new European project to support paediatric and orphan medical devices

Spotlight on: Rare Disorders New Zealand

Recent scientific publications by ERNs

Endo-ERN: Apply for the 2025 Clinical Exchange Program

Understanding the Endo-ERN Core Registry: A new resource for patients

New EpiCARE guidelines for submitting to CTIS

Recap of the first EuroBloodNet Preceptorship

New ReCONNET flyer on videocapillaroscopy

VASCERN Summer School 2024 recap

2023 Activity Report available now!

New Orphanet Report Series on Prevalence published

Leveraging new technologies to accelerate rare disease diagnosis: Recommendations from an IRDiRC Task Force

Understanding the rare disease funding landscape: Findings of the IRDiRC Funding Models for Rare Diseases Research Task

Towards better social protection for PLWRD: A new partnership between RDI & the P4H Network

Inequities in the US rare disease community: Findings from a NORD & RDDC survey

Towards the implementation of Canada's National Strategy for Drugs for Rare Diseases: Two new reports published

Apply to join the ERDERA Multistakeholder Advisory Board

New EMA & HMA guiding principles on LLM use

Public consultation on implementing joint scientific consultations under the HTA Regulation

Commission guidance on the validity of clinical studies for Health Technology Assessment

New CTIS portal now live

EURORDIS: Call for manuscripts on drug repurposing

EMA: Six new market authorisations with an orphan designation from July-September 2024

EMA: Thirty-four orphan designations accorded by the COMP from July to September 2024

FDA: Fifteen new market authorisations with orphan designation granted from July to September 2024

FDA: One hundred thirty-eight new orphan designations approved from July to September 2024

Experience of an Undiagnosed Diseases Program in China to accelerate diagnosis and improve rare disease care

Understanding barriers to genomic NBS in Europe: A Delphi consensus study

Common factors affecting health-related quality of life across rare diseases

Assessing registry feasibility for common core datasets: The SATURN methodology

Credits

OrphaNews, The Newsletter for the Rare Diseases Community.
Editor-in-chief: Ana Rath
Associate Editor: Charlotte Rodwell
Editor: Madeline Cuillerier
Scientific editor: Perrine Renard

Contact Us
Editorial Board: Victoria Hedley, Yann Le Cam, Charlotte Rodwell, Anna Bucsics, Ivana Cattaneo, Daria Julkowska, Alexis Arzimanoglou, Holm Graessner, Julie Bruyere-Zrelli, Andrea Osvoll, Stanislav Ostapenko, Valentina Bottarelli, Dave Pearce, Samantha Parker, Alexandra Heumber Perry, Perrine Renard

ADVISORY EDITORIAL BOARD
Orphanet Partner Country Representatives: Romi Armando (Argentina), Tamara Sarkisan (Armenia),  Till Voigtlander (Austria), Elfriede Swinnen (Belgium), Rumen Stefanov (Bulgaria), Ingeborg Barisic (Croatia), Marios Antoniades (Cyprus), Milan Macek (Czech Republic), Vallo Tillmann (Estonia), Helena Kääriäinen (Finland), Stefanie Weber (Germany), Eileen Treacy (Ireland), Annick Raas-Rothschild (Israel), Bruno Dallapiccola (Italy), Atsuhiko Kawamoto (Japan), Madara Auzenbaha (Latvia), Birute Tumiene (Lithuania),  Dijana Plaseska Karanfilska (North Macedonia), Neville Calleja (Malta) Abdelaziz Sefiani (Morocco), Wendy va Zelst-Stam (Netherlands), Stein Are Aksnes (Norway), Krystyna Chrzanowska (Poland), Cristina Rusu (Romania), Sergey Kutsev (Russia), Dragica Radojkovic (Serbia), Gabriela Hrčková (Slovakia), Luca Lovrecic (Slovenia), Francesc Palau (Spain), Rula Zain (Sweden), Loredana D'Amato Sizonenko (Switzerland), Dorra H’mida-Ben Brahim (Tunisia), Ugur Ozbek (Turkey), Sarah Stevens (UK)

Country Correspondants: Gareth Baynam (Australia)
Disclaimer: The content of newsletter represents the views of the Editorial Board only and is his/her sole responsibility; it cannot be considered to reflect the views of its financers.